Literature DB >> 12114259

Glucocorticoid receptor downregulation in early diagnosed rheumatoid arthritis.

A Margriet Huisman1, A Amalia Van Everdingen, Marion J G Wenting, Dick R Siewertsz Van Reesema, Floris P J G Lafeber, Johannes W G Jacobs, Johannes W J Bijlsma.   

Abstract

In patients with rheumatoid arthritis (RA) with a mean duration of six years, glucocorticoid receptor (GR) downregulation has been reported without change in cortisol levels. This phenomenon might play a role in the etiopathogenesis of RA. If this is the case, GR downregulation should also be found in early-diagnosed RA. We compared GR expression and cortisol levels of early RA patients with those of sex and age matched healthy controls. In early (disease duration less than one year) RA patients (52F/29M; mean [SE] age 63 +/- 2 years) and in 39 controls (23F/16M; mean age 63 +/- 2 years) blood samples were taken between 8:00 and 10:00 a.m. GR expression (GR number), cortisol levels (fluorescence polarization immunoassay, FPIA), ESR, CRP, and the presence of swollen and painful knees were determined. RA was diagnosed according to the ACR classification criteria. In early RA a significantly lower GR expression was found compared to controls. Interestingly, cortisol levels were also significantly lower. Both findings were due to the observed differences in the female population. In the male population no differences were found. No correlations were found among parameters of disease activity, nor was there a relation between GR expression and serum cortisol levels. In female patients with early-diagnosed RA a decrease in glucocorticoid receptor expression was found as well as a decrease in cortisol levels. Since normal glucocorticoid receptor expression was found in the male population with early-diagnosed RA, it remains questionable if glucocorticoid receptor expression is causally involved in pathogenesis of RA.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12114259     DOI: 10.1111/j.1749-6632.2002.tb04202.x

Source DB:  PubMed          Journal:  Ann N Y Acad Sci        ISSN: 0077-8923            Impact factor:   5.691


  3 in total

Review 1.  Glucocorticoid sensitivity in health and disease.

Authors:  Rogier A Quax; Laura Manenschijn; Jan W Koper; Johanna M Hazes; Steven W J Lamberts; Elisabeth F C van Rossum; Richard A Feelders
Journal:  Nat Rev Endocrinol       Date:  2013-10-01       Impact factor: 43.330

2.  In vitro glucocorticoid sensitivity is associated with clinical glucocorticoid therapy outcome in rheumatoid arthritis.

Authors:  Rogier A M Quax; Jan W Koper; Pascal H P de Jong; Ramona van Heerebeek; Angelique E Weel; Anne M Huisman; Derkjen van Zeben; Frank H de Jong; Steven W J Lamberts; Johanna M W Hazes; Richard A Feelders
Journal:  Arthritis Res Ther       Date:  2012-08-24       Impact factor: 5.156

Review 3.  Neural immune pathways and their connection to inflammatory diseases.

Authors:  Farideh Eskandari; Jeanette I Webster; Esther M Sternberg
Journal:  Arthritis Res Ther       Date:  2003-09-23       Impact factor: 5.156

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.